🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

F-18 Sodium Fluoride PET/CT-Guided Pain Palliation in Chronic Plantar Fasciitis: A Comparative Study of ¹⁷⁷Lutetium-Corticosteroid-Local Anaesthetic Injection vs Corticosteroid-Local Anaesthetic Injection

RecruitingNAAges 18 Years - 80 YearsAllPost Graduate Institute of Medical Education and …
NCT07907250 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Study type: Prospective, randomized, comparative pilot clinical study. Purpose of the study: The goal of this study is to evaluate whether adding low-dose, F-18 sodium fluoride (NaF) PET/CT-guided intralesional Lutetium-177 therapy to corticosteroid and local anaesthetic injection provides better pain relief and functional improvement than PET/CT-guided corticosteroid and local anaesthetic injection alone in patients with chronic plantar fasciitis who have not responded to conservative treatment for more than six months. Participant population: Adults aged 18-80 years with chronic plantar fasciitis lasting more than six months, failure of conservative treatment, a baseline visual analogue scale (VAS) pain score of ≥4, and focal uptake at the plantar fascia insertion on F-18 NaF PET/CT. The study plans to recruit 40 participants, with 20 participants in each group. Primary Outcomes: 1

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Age 18-80 years with chronic plantar fasciitis (\>6 months). 2. Failed to conservative therapy. 3. Baseline VAS ≥4. 4. Focal uptake at plantar fascia insertion on F-18 NaF PET/CT. Exclusion Criteria: 1. Prior radiation therapy to the foot/heel. 2. Active infection at the injection site or systemic infection. 3. Pregnancy or lactation. (Pregnancy test for women of childbearing potential.) 4. Coagulopathy (INR \>1.5 or platelets \<100,000/µL) is not correctable. 5. Uncontrolled diabetes or severe peripheral vascular disease affecting wound healing. 6. Known allergy to agents would be used for local anaesthesia or to any component of the injection.
💊

What it tests

  • Patients receiving F-18 NaF PET/CT-guided Lutetium-177 - corticosteroid - local anesthetic
  • Patients receiving F-18 sodium fluoride PET/CT-guided corticosteroid - local anaesthetic
📍

Where

1 site
Postgraduate Institute of Medical Education and Research, Chandigarh
Chandigarh, India
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy